Appendix 4D and Half Year Accounts
Filed with ASX · · 27 pages · English
Story so far
Earlier from Anagenics
- Record 2M sales for Cellmid FGF5 inhibitors
- Cellmid quarterly operational update
- Cellmid placement to strategic investor
- Cellmid secures new US retail partner for evolis
- Cellmid opens first concept store in Tokyo
Later from Anagenics
- Cellmid signs distribution agreement for Fillerina
- Appendix 4C - quarterly
- Cellmid secures Bloomingdales USA partnership for evolis
- Cellmid to commence selling of evolis into Chinese market
- Cellmid updates on distribution of evolis
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics